In-stent Restenosis Lesion

1

Review clinical trials related to In-stent Restenosis Lesion. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis

This study aims to evaluate, through a multicenter, prospective, double-blind, randomized, placebo-controlled clinical trial, whether immunosuppressive therapy improves target lesion-related cardiovascular outcomes compared to placebo treatment in patients with Rapid rEcurrence of Coronary Unexplained in-stent Restenosis (RECUR).

Participants needed: 52
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: China National Center for Cardiovascular DiseasesUpdated: May 21, 2025
Eligibility criteria

Age ≥ 18 years old [+4]